These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26454433)

  • 1. Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review.
    Olusanya BO; Slusher TM
    World J Pediatr; 2015 Nov; 11(4):293-9. PubMed ID: 26454433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis.
    Olusanya BO; Osibanjo FB; Slusher TM
    PLoS One; 2015; 10(2):e0117229. PubMed ID: 25675342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden and management of neonatal jaundice in Nigeria: A scoping review of the literature.
    Olusanya BO; Osibanjo FB; Mabogunje CA; Slusher TM; Olowe SA
    Niger J Clin Pract; 2016; 19(1):1-17. PubMed ID: 26755212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency.
    Olusanya BO; Emokpae AA; Zamora TG; Slusher TM
    Acta Paediatr; 2014 Nov; 103(11):1102-9. PubMed ID: 24990658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and causes of severe neonatal hyperbilirubinemia in Canada.
    Sgro M; Campbell D; Shah V
    CMAJ; 2006 Sep; 175(6):587-90. PubMed ID: 16966660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium?
    Kaplan M; Bromiker R; Hammerman C
    Neonatology; 2011; 100(4):354-62. PubMed ID: 21968213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.
    Olusanya BO; Ogunlesi TA; Kumar P; Boo NY; Iskander IF; de Almeida MF; Vaucher YE; Slusher TM
    BMC Pediatr; 2015 Apr; 15():39. PubMed ID: 25884679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the Criteria for Exchange Transfusion for Severe Neonatal Hyperbilirubinemia in Resource-Limited Settings.
    Olusanya BO; Imam ZO; Emokpae AA; Iskander IF
    Neonatology; 2016; 109(2):97-104. PubMed ID: 26594786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.
    Kaplan M; Hammerman C; Bhutani VK
    Clin Perinatol; 2016 Jun; 43(2):325-40. PubMed ID: 27235211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why is kernicterus still a major cause of death and disability in low-income and middle-income countries?
    Olusanya BO; Ogunlesi TA; Slusher TM
    Arch Dis Child; 2014 Dec; 99(12):1117-21. PubMed ID: 25123403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
    Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK
    Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency.
    Kaplan M; Herschel M; Hammerman C; Hoyer JD; Heller GZ; Stevenson DK
    J Pediatr; 2006 Jul; 149(1):83-8. PubMed ID: 16860133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia.
    McGillivray A; Polverino J; Badawi N; Evans N
    J Pediatr; 2016 Jan; 168():82-87.e3. PubMed ID: 26477873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factor analysis for late-onset neonatal hyperbilirubinemia in Taiwanese infants.
    Huang MS; Lin MC; Chen HH; Chien KL; Chen CH
    Pediatr Neonatol; 2009 Dec; 50(6):261-5. PubMed ID: 20025138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Maternal Risk Factors in Neonatal Hyperbilirubinemia.
    Boskabadi H; Rakhshanizadeh F; Zakerihamidi M
    Arch Iran Med; 2020 Feb; 23(2):128-140. PubMed ID: 32061076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe neonatal hyperbilirubinemia in the southeast region of Turkey.
    Bozkurt Ö; Yücesoy E; Oğuz B; Akinel Ö; Palali MF; Ataş N
    Turk J Med Sci; 2020 Feb; 50(1):103-109. PubMed ID: 31731336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia.
    Atay E; Bozaykut A; Ipek IO
    J Trop Pediatr; 2006 Feb; 52(1):56-8. PubMed ID: 15917260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Neonatal Hyperbilirubinemia Decreased after the 2007 Canadian Guidelines.
    Sgro M; Kandasamy S; Shah V; Ofner M; Campbell D
    J Pediatr; 2016 Apr; 171():43-7. PubMed ID: 26852177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal impact of bilirubin-induced hearing impairment in resource-limited nations.
    Olusanya BO
    Semin Fetal Neonatal Med; 2015 Feb; 20(1):58-63. PubMed ID: 25573775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of G6PD deficiency in infants with marked hyperbilirubinemia.
    Weng YH; Chiu YW
    J Pediatr Hematol Oncol; 2010 Jan; 32(1):11-4. PubMed ID: 20051781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.